Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries HilleVax, Inc. - Common Stock (NQ: HLVX ) 1.810 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Oct 25, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about HilleVax, Inc. - Common Stock < Previous 1 2 3 Next > HLVX Stock Earnings: HilleVax Misses EPS for Q2 2024 August 09, 2024 HLVX stock results show that HilleVax missed analyst estimates for earnings per share the second quarter of 2024. Via InvestorPlace HilleVax Reports Second Quarter 2024 Financial Results and Highlights Recent Company Progress August 08, 2024 From HilleVax, Inc. Via GlobeNewswire HilleVax Announces Reduction in Force July 31, 2024 From HilleVax, Inc. Via GlobeNewswire HilleVax, Inc. (HLVX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings July 15, 2024 From Bronstein, Gewirtz & Grossman, LLC Via Business Wire (HLVX) - Analyzing HilleVax's Short Interest July 09, 2024 Via Benzinga HLVX Stock Earnings: HilleVax Beats EPS for Q4 2023 March 20, 2024 HLVX stock results show that HilleVax beat analyst estimates for earnings per share the fourth quarter of 2023. Via InvestorPlace HilleVax, Inc. (HLVX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings July 09, 2024 From Bronstein, Gewirtz & Grossman, LLC Via Business Wire Gold Falls Over 1%; HilleVax Shares Plunge July 08, 2024 Via Benzinga Stocks Hold Steady, Small Caps Rise, French Equities Slip After Surprise Win By Left-Wing Bloc: What's Driving Markets Monday? July 08, 2024 U.S. stocks started the week on a neutral note, with the S&P 500 and Nasdaq 100 indices hovering around the flatline by midday trading in New York. This comes after both indices reached fresh record... Via Benzinga Why Arhaus Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Monday's Mid-Day Session July 08, 2024 Via Benzinga GRFS Stock Alert: Grifols Pops 20% on Takeover Interest July 08, 2024 Grifols stock is up on Monday as the founding family of the company has presented a preliminary takeover offer for GRFS shares. Via InvestorPlace Why Is HilleVax (HLVX) Stock Down 87% Today? July 08, 2024 HilleVax stock is down on Monday after HLVX investors learned of a failed Phase 2b clinical trial of its norovirus vaccine for infants. Via InvestorPlace HLVX Investors Have Opportunity to Join HilleVax, Inc. Securities Fraud Investigation with the Schall Law Firm July 08, 2024 From The Schall Law Firm Via Business Wire Dow Turns Lower; Myomo Shares Jump July 08, 2024 Via Benzinga Topics Stocks Exposures US Equities Dow Jumps Over 200 Points; Greenbrier Shares Fall After Q3 Results July 08, 2024 Via Benzinga Topics Stocks Exposures US Equities Recap: HilleVax Q4 Earnings March 20, 2024 Via Benzinga Vaccine Developer HilleVax Stock Nosedives On Monday - Here's Why July 08, 2024 Shares of HilleVax fell after the release of Phase 2b trial results for HIL-214, a vaccine for norovirus-related acute gastroenteritis in infants. The study showed 5% efficacy and no significant... Via Benzinga HilleVax Reports Topline Data from NEST-IN1 Phase 2b Clinical Study of HIL-214 in Infants July 08, 2024 From HilleVax, Inc. Via GlobeNewswire Why Core & Main Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session June 04, 2024 Via Benzinga Saia, Annexon, Core Scientific And Other Big Stocks Moving Higher On Tuesday June 04, 2024 Via Benzinga Why Applied DNA Sciences Shares Are Trading Lower By Around 68%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session May 28, 2024 Via Benzinga HLVX Stock Earnings: HilleVax Misses EPS for Q1 2024 May 09, 2024 HLVX stock results show that HilleVax missed analyst estimates for earnings per share the first quarter of 2024. Via InvestorPlace HilleVax Reports First Quarter 2024 Financial Results and Highlights Recent Company Progress May 09, 2024 From HilleVax, Inc. Via GlobeNewswire HilleVax Reports Full Year 2023 Financial Results and Highlights Recent Company Progress March 20, 2024 From HilleVax, Inc. Via GlobeNewswire HilleVax to Present at Guggenheim 6th Annual Biotechnology Conference February 05, 2024 From HilleVax, Inc. Via GlobeNewswire HilleVax Announces Executive Management Appointment of Sean McLoughlin as Chief Operating Officer January 18, 2024 From HilleVax, Inc. Via GlobeNewswire Week In Review: China Biopharmas Book $9 Billion In Deals During JP Morgan Conference Week January 13, 2024 Shanghai Argo Biopharma entered 2 agreements with Novartis, out-licensing four next-gen RNAi therapeutics for $185 million upfront and a total value of $4.2 billion. Additionally, Ambrx Biopharma will... Via Talk Markets HilleVax and Kangh Announce Exclusive License Agreement for Hexavalent VLP Norovirus Vaccine Candidate Outside of China January 08, 2024 Collaboration leverages HilleVax’s leading norovirus vaccine development expertise and adds a Phase 1-ready next-generation program to HilleVax’s pipeline From HilleVax, Inc. Via GlobeNewswire HilleVax to Present at the 42nd Annual J.P. Morgan Healthcare Conference January 03, 2024 From HilleVax, Inc. Via GlobeNewswire HilleVax Reports Third Quarter 2023 Financial Results and Highlights Recent Company Progress November 09, 2023 From HilleVax, Inc. Via GlobeNewswire < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.